Alzheimer's Patients Now Less Likely to Receive Biogen's Aduhelm Treatment 0 03.05.2022 23:53 The Wall Street Journal People with Alzheimer’s disease will be less likely to receive Aduhelm because of the company’s decision to slash commercial support for the drug in the face of restricted reimbursement by the U.S. Medicare program and other insurers. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ